Lv1
60 积分 2025-09-16 加入
T cells reinforce NK cell-mediated ADCC Ronald P Taylor 1
6天前
已完结
Cytotoxic IgG: Mechanisms, functions, and applications
7天前
已完结
EGFR Exon 20 insertions in NSCLC: from biology to amivantamab, optimal treatment strategy and emerging therapeutics
20天前
已完结
EGFR Exon 20 insertions in NSCLC: from biology to amivantamab, optimal treatment strategy and emerging therapeutics
20天前
已关闭
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
20天前
已完结
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
1个月前
已完结
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial
1个月前
已完结
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
1个月前
已完结
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
1个月前
已完结
Pleural mesothelioma
1个月前
已完结
皖公网安备34019202002308
